Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study

INTRODUCTION: Osteoporosis is one of the important bone abnormalities in chronic kidney disease-mineral and bone disorder (CKD-MBD) and still lacks a sensitive biomarker to diagnose. Fibroblast growth factor 21 (FGF21) can stimulate bone loss in patients with diabetes and increase in CKD patients. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lili, Li, Min, Zha, Qianqian, Yang, Min, Yu, Jirong, Pan, Mingming, Yin, Qing, Jiang, Liqiong, Xia, Meixia, Liu, Bi-Cheng, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135985/
https://www.ncbi.nlm.nih.gov/pubmed/34011291
http://dx.doi.org/10.1186/s12882-021-02393-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135985/
https://www.ncbi.nlm.nih.gov/pubmed/34011291
http://dx.doi.org/10.1186/s12882-021-02393-z

Ejemplares similares